Sabin Vaccine Institute

8 articles about Sabin Vaccine Institute

• Sabin Vaccine Institute Leads Public and Private Sector Fight to Prevent HPV and End Cervical Cancer with Global HPV Consortium Launch in Kuala Lumpur

  9/4/2023

  The Global HPV Consortium, a worldwide public and private collaboration focused on accelerating prevention of Human Papillomavirus and eliminating cervical cancer, launched in Kuala Lumpur, Malaysia.

• Vaccine R&D Leader Kathrin Jansen and Immunologist Kizzmekia Corbett Awarded Sabin’s Gold Medal and Rising Star Respectively

  12/7/2022

  The Sabin Vaccine Institute honored two extraordinary scientists for their breakthrough vaccine research that changed the course of the COVID-19 pandemic, advanced public health, and saved countless lives.

• Sabin Receives Additional $21.8 Million From BARDA to Advance Marburg Vaccine

  9/14/2022

  The Sabin Vaccine Institute announced it is receiving an additional $21.8 million under an existing contract with the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services.

• Vaccine Science and Policy Experts Call for Transformation of Vaccine R&D Enterprise

  5/4/2021

  As the world continues to grapple with the significant impact of the COVID-19 pandemic, the global community faces an urgent need to develop an efficient, coordinated and sustainable model for a healthy and well-functioning vaccine research and development ecosystem.

• Sabin Vaccine Institute’s Boost Community Prepares Immunization Professionals to Lead During the COVID-19 Crisis  

  6/16/2020

  Amid the evolving global challenges posed by the novel coronavirus pandemic, immunization professionals must now grapple with deploying routine immunization services in a daunting and ever-shifting landscape.

• 

  Biopharma, Regulators and Researchers Turn Their Focus to Universal Flu Vaccines

  5/17/2018

  The 2017/2018 influenza season was considered one of the worst, made more so by the ineffectiveness of the season’s flu vaccine. The FDA is focusing partially on simply determining why this year’s flu vaccine missed the mark.

• Sabin Vaccine Institute Issues Statement on New Universal Flu Vaccine Development Grand Challenge

  4/27/2018

  The new $12 million Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development from the Bill & Melinda Gates Foundation and Lucy and Larry Page is an important and necessary step toward finding a game-changing solution to end the threat of flu, according to experts at the Sabin Vaccine Institute (Sabin), a leading advocate for expanding vaccine access and uptake across the world.

• Sabin to Tackle Pandemic Flu

  1/8/2018

  Sabin Vaccine Institute, is pleased to announce a new three-year $6.6M grant to help speed the development of next generation influenza vaccines and support related immunization issues.